RP Bio Inc. (KOSDAQ:314140)

RP Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	50,958	64,131	43,765	74,964	102,515	-
Market Cap Growth	12.21%	46.53%	-41.62%	-26.88%	-	-
Enterprise Value	55,779	68,636	58,375	92,754	118,331	-
Last Close Price	5880.00	7400.00	5015.60	8591.08	12389.51	-
PE Ratio	10.87	13.70	-	13.79	23.75	-
PS Ratio	0.37	0.47	0.35	0.50	0.74	-
PB Ratio	0.48	0.60	0.43	0.73	1.13	-
P/TBV Ratio	0.48	0.60	0.43	0.73	1.13	-
P/FCF Ratio	7.00	8.81	5.71	-	-	-
P/OCF Ratio	4.08	5.14	3.24	7.09	88.76	-
EV/Sales Ratio	0.41	0.50	0.47	0.61	0.86	-
EV/EBITDA Ratio	4.85	5.97	9.53	7.32	7.86	-
EV/EBIT Ratio	10.97	13.50	-	14.01	12.27	-
EV/FCF Ratio	7.67	9.43	7.61	-	-	-
Debt / Equity Ratio	0.18	0.18	0.30	0.30	0.42	0.59
Debt / EBITDA Ratio	1.69	1.69	4.93	2.43	2.54	3.64
Debt / FCF Ratio	2.67	2.67	3.94	-	-	18.23
Net Debt / Equity Ratio	0.05	0.05	0.11	0.18	0.22	0.47
Net Debt / EBITDA Ratio	0.42	0.42	1.86	1.44	1.32	2.94
Net Debt / FCF Ratio	0.66	0.66	1.48	-33.54	-4.98	14.74
Asset Turnover	0.86	0.86	0.76	0.89	0.87	0.84
Inventory Turnover	5.09	5.09	4.02	3.73	3.94	5.24
Quick Ratio	0.75	0.75	0.71	0.57	0.50	0.41
Current Ratio	1.30	1.30	1.19	1.18	1.03	0.73
Return on Equity (ROE)	4.47%	4.47%	-0.89%	5.61%	5.39%	5.73%
Return on Assets (ROA)	2.01%	2.01%	-0.27%	2.44%	3.81%	2.68%
Return on Invested Capital (ROIC)	4.57%	4.50%	-0.59%	5.49%	6.91%	5.32%
Return on Capital Employed (ROCE)	4.50%	4.50%	-0.60%	6.10%	10.20%	8.10%
Earnings Yield	9.19%	7.30%	-2.07%	7.25%	4.21%	-
FCF Yield	14.28%	11.34%	17.53%	-0.73%	-3.89%	-
Buyback Yield / Dilution	-0.18%	-0.18%	0.12%	-21.46%	-8.34%	1.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.